Peter Zucker
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Genetics top 5%
- Diabetes and associated disorders
Papers in
- Co-authors
- Guillermo Arreaza (5 shared papers)Terry L. Delovitch (6 shared papers)Qing‐Sheng Mi (5 shared papers)Shayan Sharif (3 shared papers)T L Delovitch (2 shared papers)Mark J. Cameron (2 shared papers)Subrata Chakrabarti (2 shared papers)Stephen W. Chensue (2 shared papers)
- Journals
- Diabetes (6 papers)Carcinogenesis (4 papers)Transplantation (4 papers)Annals of the New York Academy of Sciences (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Peter Zucker
32 papers receiving 1.4k citations
Peter Zucker's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 799
- Genetics 555
- Endocrinology, Diabetes and Metabolism 222
- Surgery 384
- Biochemistry 33
Countries citing papers authored by Peter Zucker
This map shows the geographic impact of Peter Zucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Zucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Zucker more than expected).
Fields of papers citing papers by Peter Zucker
This network shows the impact of papers produced by Peter Zucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Zucker. The network helps show where Peter Zucker may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Zucker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Hit paper breakdown → | 2001 | 513 |
| 2 | 1997 | 191 | |
| 3 | 2003 | 88 | |
| 4 | 1997 | 77 | |
| 5 | 1997 | 72 | |
| 6 | 2004 | 67 | |
| 7 | 2003 | 57 | |
| 8 | 2002 | 50 | |
| 9 | 1990 | 48 | |
| 10 | 2002 | 40 | |
| 11 | 1998 | 29 | |
| 12 | 1997 | 29 | |
| 13 | 2002 | 26 | |
| 14 | 1975 | 24 | |
| 15 | 2001 | 23 | |
| 16 | 1975 | 23 | |
| 17 | 2004 | 16 | |
| 18 | 1997 | 13 | |
| 19 | 1989 | 13 | |
| 20 | 1985 | 11 |
About Peter Zucker
Peter Zucker is a scholar working on Genetics, Surgery, Immunology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes and associated disorders (16 papers), Pancreatic function and diabetes (16 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers), Diet, Metabolism, and Disease (4 papers), Diabetes Management and Research (2 papers), Polyamine Metabolism and Applications (2 papers) and Sulfur Compounds in Biology (2 papers). The work is most often cited by research in Immunology (799 citations), Genetics (555 citations), Endocrinology, Diabetes and Metabolism (222 citations), Surgery (384 citations) and Biochemistry (33 citations). Peter Zucker has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Guillermo Arreaza, Terry L. Delovitch, Qing‐Sheng Mi, Shayan Sharif, T L Delovitch, Mark J. Cameron, Subrata Chakrabarti, Stephen W. Chensue, Robert M. Strieter and Olga V. Naidenko. Their work appears in journals such as Diabetes, Carcinogenesis, Transplantation, Annals of the New York Academy of Sciences and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.